Altogether, these results support that 10−10M E4 (therapeutic) does not induce any transcription activity in breast cancer cells, corroborating the lack of ERα signaling upregulation observed by Western Blot and IHC staining in vivo. The gene discussed is ESR1; the disease is breast cancer.